Related Experiment Video
Updated: Aug 27, 2025
06:54
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
2.8K
OEA loaded liposomes with the neuroprotective effect for stroke therapy
Shichao Wu1,2,3, Xiangrui Yang1,2,3
1Department of Nuclear Medicine, Xiangya Hosptal, Central South University, Changsha, Hunan, China.
Frontiers in Chemistry
|September 26, 2022
Summary
Researchers developed novel N-oleoylethanolamine (OEA) liposomes for stroke therapy. This OEA liposome nanoformulation significantly improved survival rates and neurological function in stroke models, offering a promising new treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Nanotechnology
Background:
- Stroke presents a significant global health challenge with limited therapeutic options.
- Existing stroke therapies face challenges in efficacy and delivery.
- N-oleoylethanolamine (OEA) is an endogenous compound with potential therapeutic properties.
Purpose of the Study:
- To develop a novel neuroprotective nanoformulation for stroke treatment.
- To enhance the solubility and bioavailability of N-oleoylethanolamine (OEA).
- To evaluate the in vivo efficacy of OEA-loaded liposomes.
Main Methods:
- Preparation of OEA-loaded liposomes for intravenous administration.
- Assessment of neuroprotective effects in a rat stroke model (Middle Cerebral Artery Occlusion - MCAO).
- Evaluation of survival rates, neurological function, neuronal apoptosis, and inflammatory responses.
Main Results:
- OEA liposomes significantly increased the survival rate of MCAO rats from 41.7% to 75%.
- Significant improvement in neurological functional deficits was observed in the OEA liposome group.
- OEA liposomes effectively inhibited neuronal apoptosis and reperfusion inflammation.
Conclusions:
- OEA liposomes represent a promising nanoformulation for enhancing OEA's therapeutic potential.
- The developed nanoformulation demonstrates significant neuroprotective effects against stroke.
- OEA liposomes show great potential for clinical application in anti-stroke therapy.
